HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

BACKGROUND: Chemoradiotherapy (CRT) is the standard of care for patients diagnosed with locally advanced cervical cancer (LACC), a human papillomavirus (HPV)-related cancer that relapses in 30%-60% of patients. This study aimed to (i) design HPV droplet digital PCR (ddPCR) assays for blood detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabel, L., Bonneau, C., Bernard-Tessier, A., Héquet, D., Tran-Perennou, C., Bataillon, G., Rouzier, R., Féron, J.-G., Fourchotte, V., Le Brun, J.-F., Benoît, C., Rodrigues, M., Scher, N., Minsat, M., Legrier, M.-E., Bièche, I., Proudhon, C., Sastre-Garau, X., Bidard, F.-C., Jeannot, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164037/
https://www.ncbi.nlm.nih.gov/pubmed/34022731
http://dx.doi.org/10.1016/j.esmoop.2021.100154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164037/
https://www.ncbi.nlm.nih.gov/pubmed/34022731
http://dx.doi.org/10.1016/j.esmoop.2021.100154

Ejemplares similares